Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation

Jae Seon Eo, Jin Chul Paeng, Dong Soo Lee

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Currently, nuclear imaging such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) is increasingly used in the management of liver malignancy. 18F-fluorodeoxyglucose (FDG)-PET is the most widely used nuclear imaging in liver malignancy as in other cancers, and has been reported to be effective in diagnosis, response monitoring, recurrence evaluation, and prognosis prediction. Other PET imaging such as 11C-acetate PET is also used complementarily to FDG-PET in diagnosis of liver malignancy. Additionally, image-based evaluation of regional hepatic function can be performed using nuclear imaging. Those imaging modalities are also effective for candidate selection, treatment planning, and perioperative evaluation in liver surgery and transplantation. Recently, nuclear imaging has been actively adopted in the transarterial radioembolization therapy of liver malignancy, according to the concept of theragnosis. With the development of new hybrid imaging technologies such as PET/magnetic resonance imaging and SPECT/CT, nuclear imaging is expected to be more useful in the management of liver malignancy, particularly regarding liver surgery and transplantation. In this review, the efficacy and roles of nuclear imaging methods in diagnosis, transplantation and theragnosis are discussed.

Original languageEnglish
Pages (from-to)5375-5388
Number of pages14
JournalWorld Journal of Gastroenterology
Volume20
Issue number18
DOIs
Publication statusPublished - 2014 May 14

Fingerprint

Positron-Emission Tomography
Liver Transplantation
Liver
Neoplasms
Single-Photon Emission-Computed Tomography
Multimodal Imaging
Fluorodeoxyglucose F18
Transplantation
Magnetic Resonance Imaging
Technology
Recurrence
Therapeutics

Keywords

  • Liver malignancy
  • Nuclear imaging
  • Positron emission tomography-computed tomography
  • Theragnosis
  • Transplantation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation. / Eo, Jae Seon; Paeng, Jin Chul; Lee, Dong Soo.

In: World Journal of Gastroenterology, Vol. 20, No. 18, 14.05.2014, p. 5375-5388.

Research output: Contribution to journalReview article

@article{dabb492d089545e9887fdb675b1971e3,
title = "Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation",
abstract = "Currently, nuclear imaging such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) is increasingly used in the management of liver malignancy. 18F-fluorodeoxyglucose (FDG)-PET is the most widely used nuclear imaging in liver malignancy as in other cancers, and has been reported to be effective in diagnosis, response monitoring, recurrence evaluation, and prognosis prediction. Other PET imaging such as 11C-acetate PET is also used complementarily to FDG-PET in diagnosis of liver malignancy. Additionally, image-based evaluation of regional hepatic function can be performed using nuclear imaging. Those imaging modalities are also effective for candidate selection, treatment planning, and perioperative evaluation in liver surgery and transplantation. Recently, nuclear imaging has been actively adopted in the transarterial radioembolization therapy of liver malignancy, according to the concept of theragnosis. With the development of new hybrid imaging technologies such as PET/magnetic resonance imaging and SPECT/CT, nuclear imaging is expected to be more useful in the management of liver malignancy, particularly regarding liver surgery and transplantation. In this review, the efficacy and roles of nuclear imaging methods in diagnosis, transplantation and theragnosis are discussed.",
keywords = "Liver malignancy, Nuclear imaging, Positron emission tomography-computed tomography, Theragnosis, Transplantation",
author = "Eo, {Jae Seon} and Paeng, {Jin Chul} and Lee, {Dong Soo}",
year = "2014",
month = "5",
day = "14",
doi = "10.3748/wjg.v20.i18.5375",
language = "English",
volume = "20",
pages = "5375--5388",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "18",

}

TY - JOUR

T1 - Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation

AU - Eo, Jae Seon

AU - Paeng, Jin Chul

AU - Lee, Dong Soo

PY - 2014/5/14

Y1 - 2014/5/14

N2 - Currently, nuclear imaging such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) is increasingly used in the management of liver malignancy. 18F-fluorodeoxyglucose (FDG)-PET is the most widely used nuclear imaging in liver malignancy as in other cancers, and has been reported to be effective in diagnosis, response monitoring, recurrence evaluation, and prognosis prediction. Other PET imaging such as 11C-acetate PET is also used complementarily to FDG-PET in diagnosis of liver malignancy. Additionally, image-based evaluation of regional hepatic function can be performed using nuclear imaging. Those imaging modalities are also effective for candidate selection, treatment planning, and perioperative evaluation in liver surgery and transplantation. Recently, nuclear imaging has been actively adopted in the transarterial radioembolization therapy of liver malignancy, according to the concept of theragnosis. With the development of new hybrid imaging technologies such as PET/magnetic resonance imaging and SPECT/CT, nuclear imaging is expected to be more useful in the management of liver malignancy, particularly regarding liver surgery and transplantation. In this review, the efficacy and roles of nuclear imaging methods in diagnosis, transplantation and theragnosis are discussed.

AB - Currently, nuclear imaging such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) is increasingly used in the management of liver malignancy. 18F-fluorodeoxyglucose (FDG)-PET is the most widely used nuclear imaging in liver malignancy as in other cancers, and has been reported to be effective in diagnosis, response monitoring, recurrence evaluation, and prognosis prediction. Other PET imaging such as 11C-acetate PET is also used complementarily to FDG-PET in diagnosis of liver malignancy. Additionally, image-based evaluation of regional hepatic function can be performed using nuclear imaging. Those imaging modalities are also effective for candidate selection, treatment planning, and perioperative evaluation in liver surgery and transplantation. Recently, nuclear imaging has been actively adopted in the transarterial radioembolization therapy of liver malignancy, according to the concept of theragnosis. With the development of new hybrid imaging technologies such as PET/magnetic resonance imaging and SPECT/CT, nuclear imaging is expected to be more useful in the management of liver malignancy, particularly regarding liver surgery and transplantation. In this review, the efficacy and roles of nuclear imaging methods in diagnosis, transplantation and theragnosis are discussed.

KW - Liver malignancy

KW - Nuclear imaging

KW - Positron emission tomography-computed tomography

KW - Theragnosis

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=84900397125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900397125&partnerID=8YFLogxK

U2 - 10.3748/wjg.v20.i18.5375

DO - 10.3748/wjg.v20.i18.5375

M3 - Review article

VL - 20

SP - 5375

EP - 5388

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 18

ER -